Jingli Xu

897 total citations
36 papers, 433 citations indexed

About

Jingli Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jingli Xu has authored 36 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Jingli Xu's work include Cancer Mechanisms and Therapy (8 papers), Ferroptosis and cancer prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Jingli Xu is often cited by papers focused on Cancer Mechanisms and Therapy (8 papers), Ferroptosis and cancer prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Jingli Xu collaborates with scholars based in China, South Korea and Hong Kong. Jingli Xu's co-authors include Yuan Li, Jiang‐Jiang Qin, Xiangdong Cheng, Can Hu, Zhiyuan Xu, Handong Xu, Zhiyuan Xu, Yanqiang Zhang, Tianye Lin and Qingwen Zhang and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Jingli Xu

34 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingli Xu China 13 169 117 94 90 88 36 433
Ronglin Yan China 11 235 1.4× 159 1.4× 94 1.0× 89 1.0× 91 1.0× 24 531
Zhengtian Li China 10 220 1.3× 69 0.6× 81 0.9× 112 1.2× 87 1.0× 25 442
Konrad Zaręba Poland 11 161 1.0× 84 0.7× 66 0.7× 63 0.7× 131 1.5× 46 436
Quanbao Zhang China 16 252 1.5× 106 0.9× 81 0.9× 135 1.5× 164 1.9× 40 603
Pihong Li China 12 243 1.4× 56 0.5× 61 0.6× 107 1.2× 86 1.0× 23 456
Changyuan Wei China 10 186 1.1× 54 0.5× 53 0.6× 92 1.0× 99 1.1× 25 407
Tung‐Cheng Chang Taiwan 12 168 1.0× 120 1.0× 66 0.7× 88 1.0× 221 2.5× 34 449

Countries citing papers authored by Jingli Xu

Since Specialization
Citations

This map shows the geographic impact of Jingli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingli Xu more than expected).

Fields of papers citing papers by Jingli Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingli Xu. The network helps show where Jingli Xu may publish in the future.

Co-authorship network of co-authors of Jingli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingli Xu. A scholar is included among the top collaborators of Jingli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingli Xu. Jingli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jingli, Yanqiang Zhang, Qianyu Zhao, et al.. (2025). GPX4 knockdown suppresses M2 macrophage polarization in gastric cancer by modulating kynurenine metabolism. Theranostics. 15(12). 5826–5845. 3 indexed citations
2.
Xu, Jingli, et al.. (2025). The role of MHC molecules in cancer immunotherapy: Insights into tumor immune evasion and therapeutic strategies. Critical Reviews in Oncology/Hematology. 218. 105057–105057.
3.
Hu, Can, Jingli Xu, Yanqiang Zhang, et al.. (2025). Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis. Redox Biology. 80. 103519–103519. 3 indexed citations
4.
Zhu, Weiwei, Siwei Pan, Jingli Xu, et al.. (2025). Inhibition of integrin α3 suppresses gastric cancer progression via STAT3-mediated regulation of SLC1A5-dependent glutamine uptake. Journal of Gastroenterology. 60(12). 1496–1512.
5.
Xu, Jingli, et al.. (2025). Hexahydrocurcumin suppresses hepatocellular carcinoma by regulating TRIM23/MBNL1 pathway. Scientific Reports. 15(1). 22541–22541. 1 indexed citations
6.
Wang, Yuqi, Jingli Xu, Qianyu Zhao, et al.. (2024). The role of reactive oxygen species in gastric cancer. Cancer Biology and Medicine. 21(9). 1–14. 1 indexed citations
7.
Hu, Simeng, Can Hu, Jingli Xu, et al.. (2024). The estrogen response in fibroblasts promotes ovarian metastases of gastric cancer. Nature Communications. 15(1). 8447–8447. 9 indexed citations
8.
Ding, Guangyu, Xiaoliang Shi, Jingli Xu, et al.. (2024). Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment. Nature Communications. 15(1). 3771–3771. 6 indexed citations
9.
Hu, Can, et al.. (2024). F-box proteins and gastric cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects. International Journal of Medical Sciences. 21(8). 1575–1588. 3 indexed citations
10.
Zhu, Weiwei, Siwei Pan, Jiaqing Zhang, et al.. (2024). The role of hyperthermia in the treatment of tumor. Critical Reviews in Oncology/Hematology. 204. 104541–104541. 11 indexed citations
11.
Li, Shengli, Yuan Li, Zhiyuan Xu, et al.. (2023). Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature Communications. 14(1). 778–778. 24 indexed citations
12.
Xu, Handong, Can Hu, Yi Wang, et al.. (2023). Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism. Oncogene. 42(24). 1994–2006. 25 indexed citations
13.
Zhang, Jiaqing, Can Hu, Jingli Xu, et al.. (2023). The role of macrophages in gastric cancer. Frontiers in Immunology. 14. 1282176–1282176. 12 indexed citations
14.
Hu, Can, Jingli Xu, Yuan Li, et al.. (2023). Polyphyllin B Suppresses Gastric Tumor Growth by Modulating Iron Metabolism and Inducing Ferroptosis. International Journal of Biological Sciences. 19(4). 1063–1079. 36 indexed citations
15.
Hu, Can, et al.. (2022). Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 8 indexed citations
16.
Li, Yuan, Shaowei Mo, Zhiyuan Xu, et al.. (2021). p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier. Pharmacological Research. 165. 105411–105411. 16 indexed citations
17.
Xu, Jingli, Yuan Li, Yancheng Tang, et al.. (2020). The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?. Frontiers in Cell and Developmental Biology. 8. 621428–621428. 54 indexed citations
19.
Chen, Da, et al.. (2018). [Electroacupuncture Intervention Reduces Post-surgical Pain of Patients Undergoing Total Knee Arthroplasty].. PubMed. 43(10). 616–21. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026